[Ir(ppy) 2 7 .95 (t, J = 7.5 Hz, 4H), 7 .82 (d, J = 5.5 Hz, 2H), 7.67 (t, J = 7.7 Hz, 2H), 7.61 (t, J = 7.1 Hz, 2H), 7.17 (t, J = 6.7 Hz, 2H), 7.05 (t, J = 7.9 Hz, 2H), 6 .94 (t, J = 7.5 Hz, 2H), 6 .20 (d, J = 7.4 Hz, 2H).
[Ir(DFppy) 2 (t, J = 11.6 Hz).
[Ir(2pq) 2 [Ir(pbt) 2 Hz, 2H), 6.96 (t, J = 7.6 Hz, 2H), 6 .35 (d, J = 8.5 Hz, 2H), 6 .30 (d, J = 7.5 Hz, 2H).
Crystal structure analysis
Single crystals of OnIr3 were obtained. The crystal structure was obtained on a Rigaku R-AXIS SPIDER IP diffractometer with graphite monochromated Mo Ka radiation (λ = 0.71073 Å). An absorption correction was applied with the SADABS program. The structure solution and full-matrix least-squares refinement, based on F 2 , was performed with the Shelxtl-2014 and OLEX2 program packages. 4, 5 The disordered solvent molecules were removed with the SQUEEZE S7 routine in the PLATON-2015 software. 6 All non-hydrogen atoms were refined anisotropically. CCDC 1578910 contain the supplementary crystallographic data for the present paper; these data can be obtained at http://www.ccdc.cam.ac.uk/conts/retrieving.html.
Cell culture
Cells were maintained in DMEM (high glucose, Gibco) media supplemented with fetal bovine serum (10%), penicillin (100 units/mL) and streptomycin (50 units/mL) at 37 °C in a CO 2 incubator (5% CO 2 ).
Cellular localization assay
A549R cells were incubated with OnIr1-OnIr4 (2 M) at 37 °C for 8 h and then co-incubated with MitoTracker® Green FM (150 nM,) or at 37 °C for 0.5 h, then washed by PBS 3 times and visualized by laser confocal microscopy with a 63 oil-immersion objective lens immediately. The excitation wavelengths for OnIr1-OnIr4 were 405 nm, respectively, while the excitation wavelength of MTG is 488 nm. Emission filter:
(peak wavelength of OnIr1-OnIr4)  20 nm respectively, and 520  20 nm for MTG.
For ICP-MS study, exponentially growing HeLa cells were treated with OnIr1-OnIr4 (2 M) at 37 °C for 8 h, respectively. Upon completion of the incubation the cells were trypsinized, collected and counted. Each group of the cells were divided into two equal parts and processed with Nucleus Extraction Kit and Cytoplasmic and Mitochondrial Protein Extraction Kit by the manufacturer's protocols, respectively. The extractions were subsequently digested by 60% HNO 3 for over two days, and diluted by water to obtain 2% HNO 3 sample solutions for final determination. The Ir content was determined by standard curve method, and the content in nuclei, mitochondria and cytosol was calculated associated with cell numbers.
The mechanism of cellular uptake A549R cells were stained with Ir(III) complexes under different conditions by varying the temperature (4°C and 37°C) as well as the addition of metabolic inhibitors (co-stain of 2-deoxy-Dglucose and oligomycin) and endocytic inhibitors (chloroquine and NH 4 Cl)). The cells were observed under confocal microscope to determine the cellular uptake by their luminescence 7, 8 . Marked decrease in cellular uptake under low temperature, metabolic and endocytic inhibitors suggested that the compounds were taken up in an energydependent endocytic way.
Stability in FBS and culture media
An diazepam (Sigma-Aldrich) solution was used as internal reference. For this experiment, OnIr1-OnIr4 (10 μM, stock solution in ethanol) and 10 μM diazepam were added to the fetal bovine serum (FBS, 980 μL) to a total volume of 1000 μL. The solution was incubated for 0 h or 48 h at 37 °C with shaking (∼300 rpm) respectively. 2 mL of acetonitrile was added, and the mixture was centrifuged for 45 min at 1000g at 4 °C. The supernate was evaporated, and the residue was suspended in 200 μL of ethanol. The suspension was filtered and analyzed by HPLC−UV. A C18 reverse phase column was used with a flow rate of 0.5 mL/min. The runs were performed with a linear gradient of A (ethanol, Sigma-Aldrich HPLC grade) in B (distilled water). OnIr1-OnIr4 (10μM, from stock solution 1 mM in DMSO) were dissolved in DMEM (10% FBS) and incubated in 37°C for 0 h or 48 h, respectively. The absorption spectra of these mixtures was tested.
Caspase-3/7 activation detection assay
A549R cells were seeded in white-walled solid-bottomed 96-well plates at a density of 1.5 × 10 4 cells/well overnight to adhere. The cells were then treated with OnIr1-OnIr4 and cisplatin in various concentrations for 24 h, respectively. Three sets of treatments were performed: 1) OnIr1 and OnIr2 were incubated in a concentration of 0.5 μM. OnIr3 and OnIr4 were incubated in a concentration of 1 μM. Cisplatin was incubated in a concentration of 50 μM; 2) OnIr1 and OnIr2 were incubated in a concentration of 1 μM. OnIr3 and OnIr4 were incubated in a concentration of 2 μM. Cisplatin was incubated in a concentration of 100 μM; 3)
OnIr1 and OnIr2 were incubated in a concentration of 2 μM. OnIr3 and OnIr4 were incubated in a concentration of 3 μM. Cisplatin was incubated in a concentration of 150 μM; Incubation time was 24 h.
Subsequently, the cells were treated with Caspase-3/7 activity kit according to the manufacturer's protocol and the luminescence in RLUs was quantified by an Infinite M200 PRO (TECAN, Swiss).
Cell viability assay and IC50 value determination
The cell viability assay was performed by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide 
ATP depletion assay
A549R cells were seeded on white-walled non-trasparent bottomed 96-well plates at a density of 1.5 × 10 4 cells/well overnight to adhere. Three sets of treatments were performed: 1) OnIr1 and OnIr2 were incubated in a concentration of 0.5 μM. OnIr3 and OnIr4 were incubated in a concentration of 1 μM. Incubation time was 24 h; 2) OnIr1 and OnIr2 were incubated in a concentration of 1μM. OnIr3 and OnIr4 were incubated in a concentration of 2 μM. Incubation time was 24 h; 3) OnIr1 and OnIr2 were incubated in a concentration of 2 μM. OnIr3 and OnIr4 were incubated in a concentration of 3 μM. Incubation time was 24 h. Upon completion, to each well was added an equal volume of CellTitler-Glo® Luminescent Cell 10 Viability kit (Promega), the plate was vigourously vibrated and then manufacturer's protocol was followed. The chemoluminescence was measured by a TECAN Infinite M200 PRO multifunctional reader. Luminescence intensity in control wells was set to be 100%. Relative ATP contents of other groups were presented by their luminescence intensity ratios to control group and calculated with the cell viability in each incubation condition.
Transmission Electron Microscope (TEM) observation
TEM expirements were performed according to the literature description with slight alterations. 9 A549R cells were treated with OnIr1 (1 μM), OnIr2 (1 μM), OnIr3 (2 μM), OnIr4 (2 μM) and fixed overnight at 4 ºC in phosphate buffer (pH 7.4) containing 2.5% glutaraldehyde, respectively. The cells were then treated with osmium tetroxide, stained with uranyl acetate and lead citrate, and visualized with a transmission electron microscope (JEOL JEM-1400, Tokyo, Japan). Images were photographed and processed by Eversmart Jazz program (Scitex).
Western blotting
Western blotting was performed according to the literature description with slight changes. 9 GAPDH (36 kDa), VDAC1 (32 kDa), Cytochrome C (14 kDa), bcl-2 (25 kDa), bax (20 kDa), α-tubulin (52 kDa), β-actin (46 kDa), RIP3 (57kDa), LC3 (18kDa/16kDa), ERK/p-ERK (44kDa/42kDa), caspase 3 (32kDa),caspase 7 (36kDa), calpain 1 (80kDa/76kDa) and porimin (110kDa) were detected.
Cell lysate preparation
To determine the expression level of indicated proteins, Ir(III) complex treated cell lysates were prepared as described:
For cytochrome C:
A549R cells were incubated with OnIr1 (2 μM), OnIr2 (2 μM), OnIr3 (3 μM), OnIr4 (3 μM) or cisplatin (150 μM) for 24 h. Subsequently, the cells were collected and separated into two portions (cytosol and mitochondria) following the manufacturer's protocol of Cytoplasmic and Mitochondrial Protein Extraction Kit. SDS-PAGE Sample Loading Buffer (Biotime Biotechnology) was added and the samples were heated at 100 °C for 5 min, then stored at -20 °C.
For other proteins:
Two sets of treatments were performed: A549R cells were incubated with 1) 2 μM OnIr1 for 12 h, 24 h, 36 h, 48 h, respectively; 2) OnIr1 (2 μM), OnIr2 (2 μM), OnIr3 (3 μM), OnIr4 (3 μM), for 48 h. Subsequently, the cells were collected and treated with RIPA-Lysis Buffer (Biotime Biotechnology) for 30 min on ice. The lysate was centrifuged (×20000g) and the precipitate was disposed of. SDS-PAGE Sample Loading Buffer (Biotime Biotechnology) was added to the lysate and the samples were heated at 100 °C for 5 min, then store at -20 °C.
Other procedure 20 μg of proteins were analyzed by Western blot (12% acrylamide gel for cytochrome C, 10% acrylamide gel for other proteins). The PVDF membranes (0.2 μm for cytochrome C, 0.45μm for other proteins，Millipore) was used to transfer proteins (250 mA, ~30 min). The PVDF membrane were blocked with skim milk (5% in TBST) and then incubated with primary antibodies at 4 °C overnight and HRP-conjugated secondary antibodies at room temperature for 1.5 h. The signal was developed by enhanced chemiluminescence (ECL) reagent (Thermo Fisher Scientific) and visualized by X-ray films (FUJI, Japan).
Cytoskeleton observation on CLSM
Two sets of treatments are performed: A549R cells were incubated with 1) OnIr1 in 0.5 μM, 1 μM and 2 μM for 24 h; 2) OnIr1 (2 μM), OnIr2 (2 μM), OnIr3 (3 μM), OnIr4 (3 μM), for 24 h. Subsequently, the cells were fixed and treated with Actin-Tracker Green and Tubulin-Tracker Red, respectively, following the manufacture's protocol. Briefly, the treated cells were fixed by methanol and washed with Triton X-100 solution. BSA solution containing Triton X-100 and Actin-Tracker Green or Tubulin-Tracker Red was added and incubated in the dark. The fixed cells were washed with Triton X-100 solution and observed on CLSM.
Cell morphology observation
Two sets of treatments were performed: A549R cells were incubated with 1) OnIr1 (1 μM), OnIr2 (1 μM),
h. Subsequently, the cells were photographed by CLSM and vacuolization in cytosol and blebbing on plasma membrane were observed. 
Supporting Figures and Tables

